Crystal

Trial meets endpoints in safety and efficacyIND Letter from the CDSCO to optimize dosageEstablishment of an Indian Subsidiary to commercialize ProLectin-M BOSTON, MASSACHUSETTS, Dec. 28, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC.…

***Innovative multinational company conquers the second most populous country in the world with its public access and residential developments ***Cities including New Delhi, Mumbai, Bangalore, Kolkata, Goa, Hosur, Chennai, Hyderabad and…